tiprankstipranks
Benitec Biopharma Ltd (BNTC)
NASDAQ:BNTC
US Market

Benitec Biopharma (BNTC) Income Statement

Compare
259 Followers

Benitec Biopharma Income Statement

Last quarter (Q2 2025), Benitec Biopharma's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q2, Benitec Biopharma's net income was $-7.36M. See Benitec Biopharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Jun 24Jun 23Jun 22Jun 21Jun 20
Total Revenue
$ 216.00K$ 75.00K$ 73.00K$ 59.00K$ 97.00K
Gross Profit
$ 108.00K$ -306.00K$ 64.00K$ -64.00K$ -171.06K
Operating Expenses
$ 22.38M$ 19.16M$ 17.92M$ 13.53M$ 8.56M
Depreciation and Amortization
$ 0.00$ 381.00K$ 392.00K$ 424.00K$ 374.00K
EBITDA
$ -22.49M$ -18.70M$ -17.85M$ -13.60M$ -7.91M
Operating Income
$ -22.49M$ -19.08M$ -17.85M$ -13.60M$ -8.28M
Other Income/Expenses
$ 120.00K$ -481.00K$ -354.00K$ -286.00K$ 7.00K
Pretax Income
$ -22.37M$ -19.56M$ -18.21M$ -13.88M$ -8.27M
Net Income
$ -21.75M$ -19.56M$ -18.56M$ -13.78M$ -8.30M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -5.36$ -14.12$ -38.62$ -54.54$ -138.19
Diluted EPS
$ -5.36$ -14.12$ -38.62$ -54.54$ -138.19
Weighted Average Shares Outstanding
4.06M 1.39M 480.69K 252.67K 60.07K
Weighted Average Shares Outstanding (Diluted)
4.06M 1.39M 480.69K 252.67K 60.07K
Currency in USD

Benitec Biopharma Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis